Table 2.
Surgery details and treatment outcomes after overall treatments
| Patient No. | Interval from RT to OP (weeks) | Surgery | yp Stage* | Maintenance chemotherapy |
Pattern of failure | Last follow up (months) |
Survival |
|---|---|---|---|---|---|---|---|
| 1 | 12 | LAR, Lt. lobectomy and intraop RFA of liver |
T3N1aM1a | FOLFOX #4 | Distant at 15.7 months | 23.5 | AWD |
| 2 | 8 | LAR, Lt. oophorectomy |
T3N0M0 | A-FOLFOX #4 | None | 19.0 | NED |
| 3 | 14 | LAR, Lt. lobectomy |
T3N0M1a | None | None | 16.9 | NED |
| 4 | 7 | LAR, WR of Liver, BSO |
T3N1aM1a | FOLFOX #11 | None | 16.5 | NED |
| 5 | 14 | LAR, segmentectomy and WR of Liver |
T3N2bM1a | FOLFOX #4 | None | 15.5 | NED |
| 6 | 18 | LAR, WR of liver |
T0N1aM1a | FOLFOX #4 | None | 15.8 | NED |
Abbreviations: RT, radiation therapy; OP, operation; LAR, low anterior resection; Lt., left; intraop, intraoperative; RFA, radiofrequency ablation; WR, wedge resection; BSO, Bilateral salphingo-oophorectomy; FOLFOX, 5-fluorouracil/leucovorin/oxaliplatin; A, avastin; AWD, alive with disease; NED, no evidence of disease.
*AJCC 7th edition.